Case text (Anonymised)
At acceptance but before publication, we found article A submitted to journal A was highly similar to article B, published 5 months earlier in conference proceedings in journal B by another publisher. The abstracts were nearly identical, but the author lists and affiliations did not overlap. We asked the authors to explain this and they said article A is their own work, but it was inadvertently leaked by an unnamed medical company they work with.
We told the authors of article A that in future they must declare the role of any company in their research and consider if this may be a conflict of interests. They said their article was previously submitted 4 years ago to another publisher of journal C, who rejected it. We confirmed this with the publisher, who added that their reviewers and editor are not the authors of article B.
The authors of article A said they spoke with the first author of article B, who promised to withdraw it. Article B was retracted, with the abstract being removed and a retraction notice posted. However, the stated reason for retraction was errors. The authors of article A said they were surprised by this.
What we know appears to be consistent with the authors of article A being the genuine authors, but the authors of article A told us the company does not want to be involved in this matter and they asked to withdraw article A, which we did. We have not contacted the authors or publisher of article B. We advised the authors of article A to contact the institutions of the authors of article B and the editor and publisher of journal B; we suggested they do not necessarily need to share details of the company because proof they are the original authors and the authors of article B are not, may be enough for an investigation. The authors of article A said they would consider this.
Question(s) for the COPE Forum
• Could we have handled this case differently?
• Should we contact the publisher of article B?
• Should we ask the institution of the authors of article A and/or article B to investigate?
The Forum was updated that there has been a further development: one of the authors of article A submitted a new article to the journal, a shorter version of which was published in the conference proceedings.
Generally, COPE recommends that authorship issues should be resolved at the institutional level. Institutions are best placed to investigate these issues, especially if there was a medical device company or drug company involved who funded the work. The institution should have a record of this involvement and they may be able to provide additional information. Also, the further misconduct of one of the authors of article A may indicate a pattern of unethical behaviour which needs to be addressed by the journal, but also by the institution.
The Forum was told that the journal plans to contact the author regarding the latest submission, and ask for an explanation. The journal also plans to contact the authors of the conference proceedings to see if they have any insight as to how a different author group submitted the same work to the journal. After evaluating the responses, the journal may then contact the institutions of the authors of article A and possibly also the institutions of the authors of article B. The Forum agreed this was a sensible course of action.
The authors of the latest submission and those of the conference proceeding said they had collaborated, that the conference proceeding was preliminary work, and the authors of the conference proceeding should have been acknowledged in the submission. Because of the similar issue with the previous article by the same authors, the journal still had concerns and declined to further consider the submission. The journal is asking the institutions to investigate.